An 527 white round pill tramadol

This tablet contains 50mgs of Tramadol, the active ingredient in Ultram, it is an analgesic. Common side effects may include: nausea, drowsiness, dizzines and dry mouth.

Tramadol looks like a round or oblong pill that is white, orange, yellow, or red in color. Both brand name and generic formulations of tramadol can have these characteristics. Tramadol is a prescription opioid analgesic that can provide pain relief for forms of chronic pain and severe pain. It was previously available as Ultram and Ultram ER, and is currently available in generic and brand name formulations such as Conzip and Qdolo. As of , tramadol is classified as a Schedule IV controlled substance with a moderate potential for drug abuse. Tramadol is not available as an over-the-counter pain medication, and serious side effects of tramadol abuse may include opioid overdose, drug addiction, opiate withdrawal symptoms, and serotonin syndrome. Tramadol can look like a round or elliptical pill with a solid white, off-white, orange, yellow, or red color.

An 527 white round pill tramadol

Tramadol is a prescription medication used to treat moderate to moderately severe pain in adults. Tramadol belongs to a group of drugs called opioid analgesics, which work by blocking pain signals in the body. This medication comes in immediate release tablet and that can be taken up to 6 times a day, with or without food. Tramadol also comes in extended-release tablet and capsule forms and are taken once a day, with or without food. Do not chew, divide, or break tramadol extended-release forms. Swallow them whole. Common side effects of tramadol include nausea, constipation, dry mouth, and fatigue. Tramadol can also cause dizziness or drowsiness. Do not drive or operate heavy machinery until you know how tramadol affects you. CYP2D6 is a protein in your body that is involved in the elimination of tramadol and other drugs from your body.

The severity of the withdrawal symptoms experienced will depend on the degree of physical dependence and the dose of the antagonist administered. These imprints may indicate the distributor, manufacturer, active ingredients, and other drug information.

If you are a consumer or patient please visit this version. Tramadol hydrochloride tablets is a centrally acting analgesic. Its structural formula is:. Tramadol hydrochloride is a white, bitter, crystalline and odorless powder. It is readily soluble in water and ethanol and has a pKa of 9. Each tramadol hydrochloride tablet intended for oral administration contains 50 mg of tramadol hydrochloride. In addition, it also contains the following inactive ingredients: hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polysorbate 80, pregelatinized starch, sodium starch glycolate, and titanium dioxide.

If you are a consumer or patient please visit this version. Tramadol hydrochloride tablet is a centrally acting analgesic. Its structural formula is:. Tramadol hydrochloride is a white, bitter, crystalline and odorless powder. It is readily soluble in water and ethanol and has a pKa of 9. Each tramadol hydrochloride tablet intended for oral administration contains 50 mg of tramadol hydrochloride. In addition, it also contains the following inactive ingredients: hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polysorbate 80, pregelatinized starch, sodium starch glycolate and titanium dioxide. Tramadol hydrochloride is a centrally acting synthetic opioid analgesic. Tramadol-induced analgesia is only partially antagonized by the opiate antagonist naloxone in several animal tests. Tramadol has been shown to inhibit reuptake of norepinephrine and serotonin in vitro , as have some other opioid analgesics.

An 527 white round pill tramadol

Tramadol is a controlled substance used to treat pain. It works by changing how your brain perceives pain. This drug has boxed warnings for the following risks. Boxed warnings alert doctors and patients about drug effects that may be dangerous. Tramadol also comes as an extended-release oral capsule. Immediate-release drugs are released into the body right away.

Beautiful hairbands

Patients who have been taking opioids for briefer periods of time may tolerate a more rapid taper. Cytochrome P 3A4 Interaction The concomitant use of tramadol hydrochloride with cytochrome P 3A4 inhibitors, such as macrolide antibiotics e. Respiratory Depression Administer tramadol hydrochoride cautiously in patients at risk for respiratory depression. Tell your healthcare provider right away if you have some or all of the following symptoms of seizures: body convulsions shaking and trembling temporary loss of consciousness serotonin syndrome. Potential for Other Drugs to Affect Tramadol In vitro drug interaction studies in human liver microsomes indicate that concomitant administration with inhibitors of CYP2D6 such as fluoxetine, paroxetine, and amitriptyline could result in some inhibition of the metabolism of tramadol. The development of addiction to opioid analgesics in properly managed patients with pain has been reported to be rare. Tramadol produces peripheral vasodilation, which may result in orthostatic hypotension or syncope. Average daily doses of approximately mg of tramadol hydrochloride in divided doses were generally comparable to five doses of acetaminophen mg with codeine phosphate 30 mg TYLENOL with Codeine 3 daily, five doses of aspirin mg with codeine phosphate 30 mg daily, or two to three doses of acetaminophen mg with oxycodone hydrochloride 5 mg TYLOX daily. The major metabolic pathways appear to be N - and O- demethylation and glucuronidation or sulfation in the liver. Complex patients with comorbid pain and substance use disorders may benefit from referral to a specialist. Cases of adrenal insufficiency have been reported with opioid use, more often following greater than one month of use. No well-controlled studies have been done in humans. The concomitant use of tramadol hydrochloride and CYP3A4 inducers can decrease the plasma concentration of tramadol [see Clinical Pharmacology Anticholinergic Drugs. The remainder is excreted either as unidentified or as unextractable metabolites.

Take this medicine only as directed by your doctor. Do not take more of it, do not take it more often, and do not take it for a longer time than your doctor ordered.

Patients with Chronic Pulmonary Disease Tramadol hydrochloride-treated patients with significant chronic obstructive pulmonary disease or cor pulmonale, and those with a substantially decreased respiratory reserve, hypoxia, hypercapnia, or pre-existing respiratory depression are at increased risk of decreased respiratory drive including apnea, even at recommended dosages of tramadol hydrochloride [see Warnings and Precautions 5. When discontinuing tramadol hydrochloride, gradually taper the dosage using a patient-specific plan that considers the following: the dose of tramadol hydrochloride the patient has been taking, the duration of treatment, and the physical and psychological attributes of the patient. The relative bioavailability of immediate-release tramadol hydrochloride compared to extended-release tramadol is unknown, so conversion to extended-release formulations must be accompanied by close observation for signs of excessive sedation and respiratory depression. May not be suitable in people with a history of seizures. Tramadol is available as an immediate-release or extended-release prescription opioid painkiller in generic and brand name formulations. Available data with tramadol hydrochloride in pregnant women are insufficient to inform a drug-associated risk for major birth defects and miscarriage. After stopping a CYP3A4 inhibitor, as the effects of the inhibitor decline, the tramadol plasma concentration will decrease [see Clinical Pharmacology The administration of tramadol hydrochloride may complicate the clinical assessment of patients with acute abdominal conditions. Discontinuation of a concomitantly used cytochrome P 2D6 inhibitor may result in a decrease in tramadol plasma levels and an increase in active metabolite M1 levels, which could increase or prolong adverse reactions related to opioid toxicity and may cause potentially fatal respiratory depression. Abuse and addiction are separate and distinct from physical dependence and tolerance. Intervention: Monitor patients for signs of urinary retention or reduced gastric motility when tramadol hydrochloride is used concomitantly with anticholinergic drugs. Inform patients that tramadol hydrochloride may impair the ability to perform potentially hazardous activities such as driving a car or operating heavy machinery. We're here to help. In a randomized, blinded clinical study with to patients per group, a day titration to a daily tramadol hydrochloride dose of mg 50 mg four times per day , attained in 50 mg increments every 3 days, was found to result in fewer discontinuations due to dizziness or vertigo than titration over only 4 days or no titration.